Neurocrine Biosciences shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $6.5M | 57k | 115.22 |
| 2024-06-30 | $7.9M | 58k | 137.67 |
| 2023-12-31 | $7.8M | 59k | 131.76 |
| 2023-09-30 | $6.7M | 60k | 112.50 |
| 2023-06-30 | $5.9M | 63k | 94.30 |
| 2023-03-31 | $6.4M | 63k | 101.22 |
| 2022-12-31 | $7.7M | 64k | 119.44 |
| 2022-09-30 | $6.9M | 65k | 106.21 |
| 2022-06-30 | $6.4M | 66k | 97.48 |
| 2022-03-31 | $6.1M | 66k | 93.75 |
| 2021-12-31 | $3.9M | 46k | 85.17 |
| 2021-09-30 | $4.4M | 46k | 95.91 |
| 2021-06-30 | $4.6M | 47k | 97.32 |
| 2021-03-31 | $4.7M | 49k | 97.25 |
| 2019-03-31 | $11k | 123 | 89.43 |
| 2018-12-31 | $8.7k | 122 | 71.41 |
| 2018-09-30 | $15k | 123 | 122.95 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors